Letter of Medical Necessity - Rheumatoid Arthritis (RA)
Coverage Authorization Appeal - Granulomatosis with Polyangiitis (GPA) & Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
Letter of Medical Necessity - Granulomatosis with Polyangiitis (GPA) & Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
View more
eficacy, safety & testing
Rituxan clinical details
drug label
Rituxan prescribing information
Have more Rituxan questions?
Submit MSL Request
Learn More
Your request will be referred to the appropriate Genentech, Inc. medical professional, such as a Rituxan pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report a Rituxan issue?
ONLINE FORMReport adverse event
Learn More
You can report a Rituxan adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
prior authorization
Rituxan Prior authorization resources
NOT PROVIDED BY BRANDComplete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
NOT PROVIDED BY BRANDComplete Coverage Authorization appeals
NOT PROVIDED BY BRANDCoverage Authorization Appeal - Non Hogkin's Lymphoma (NHL) & Chronic Lymphocytic Leukemia (CLL)
Letter of Medical Necessity - Rheumatoid Arthritis (RA)
Coverage Authorization Appeal - Granulomatosis with Polyangiitis (GPA) & Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
Letter of Medical Necessity - Granulomatosis with Polyangiitis (GPA) & Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
NOT PROVIDED BY BRANDBenefits investigation resources
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
Reimbursement Information - Non Hodkins Lymphoma (NHL) & Chronic Lymphocytic Leukemia (CLL)
Reimbursement Information - Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), Pemphigus Vulgaris (PV)
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Rituxan Financial assistance options
Co-pay savings program
commercial only
Enroll in patient savings program - Non Hogkin's Lymphoma (NHL) & Chronic Lymphocytic Leukemia (CLL)
Enroll in patients savings program - Granulomatosis with Polyangiitis (GPA) & Microscopic Polyangiitis (MPA) or Pemphigus Vulgaris (PV)
Learn More
Overview
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Learn More
Overview
Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
100% free (outside of insurance)
Patient eligibility
HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
Genentech Patient Assistance Program Application Form (1/2 )- Patient Consent Form
Genentech Patient Assitance Program Application Form (2/2) - To be filled by Physician
Learn More
Overview
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Rituxan Patient education
Getting started on Rituxan
NOT PROVIDED BY BRANDInstructions For Use - Non Hodkins Lymphoma (NHL)
NOT PROVIDED BY BRANDInstructions For Use - Chronic Lymphocytic Leukemia (CLL)
NOT PROVIDED BY BRANDInstructions For Use - Rheumatoid Arthritis (RA)
NOT PROVIDED BY BRANDInstructions For Use - Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
NOT PROVIDED BY BRANDInstructions For Use - Pemphigus Vulgaris (PV)
Patient toolkit
About Rituxan - Non Hodkins Lymphoma (NHL) & Chronic Lymphocytic Leukemia (CLL)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Rituxan - Rheumatoid Arthritis (RA)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Stories - Rheumatoid Arthritis (RA)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Rituxan - Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Stories - Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Rituxan - Pemphigus Vulgaris (PV)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources - Pemphigus Vulgaris (PV)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
people also ask
Rituxan FAQs
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
Can't find what you're looking for?
Our trained staff can help you:
Please note:
Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.